AYTU Aytu BioPharma, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Wrz 22, 2026
$2,07
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$1,8052tyg. minimum
$3,0752tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$22M
Przychody
$58M
Twoje odznaki
Zakres 52 tyg.
$2–$3
Ocena Analityków
BUY
Cena Docelowa
$10
P/E
·
ROE
-57.6%
Marża Zysku Netto
-24.8%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
AYTU Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$2.07
Kapitalizacja Rynkowa (MRQ)
$22M
Przychody
$58M
ROE
-57.6%
D/E Dług/Kapitał
0.3
Zakres 52 tyg.
$2–$3
AYTU Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 6 stycznia 2023 | 1-for-20 | Odwrotny |
| 9 grudnia 2020 | 1-for-10 | Odwrotny |
| 13 sierpnia 2018 | 1-for-20 | Odwrotny |
| 29 sierpnia 2017 | 1-for-20 | Odwrotny |
| 1 lipca 2016 | 1-for-12 | Odwrotny |
| 10 czerwca 2015 | 1-for-12 | Odwrotny |
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$58M2017-06-30 → 2026-06-30
EPS·2021-06-30 → 2023-06-30
Wolny przepływ pieniężny$3M2018-06-30 → 2026-06-30
Marża netto-24.8%2018-06-30 → 2026-06-30
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | AYTU | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/S (TTM) | 0.4średnia z 5 lat ≈1.3 | ≈1.3 | 7.3 | Niedowartościowany | |
| P/B (MRQ) | 0.6średnia z 5 lat ≈2.8 | ≈2.8 | 1.1 | Niedowartościowany | |
| Cena / FCF (TTM) | 6.8 | · | · | · | |
| Cena / Przepływy pieniężne (TTM) | 6.8średnia z 5 lat ≈-7.2 | ≈-7.2 | · | · | |
| EV / Revenue (EV / Przychody) | 0.1średnia z 5 lat ≈0.1 | ≈0.1 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | -3.6 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | AYTU | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 64.0%średnia z 5 lat ≈63.3% | ≈63.3% | · | · | |
| Marża Operacyjna (TTM) | -14.4%średnia z 5 lat ≈-32.8% | ≈-32.8% | -798.8% | Najwyższa półka | |
| Marża EBITDA (TTM) | -7.6%średnia z 5 lat ≈-24.0% | ≈-24.0% | -93.9% | Najwyższa półka | |
| Marża przed opodatkowaniem (TTM) | -24.7%średnia z 5 lat ≈-38.6% | ≈-38.6% | · | · | |
| Marża Zysku Netto (TTM) | -24.8%średnia z 5 lat ≈-38.9% | ≈-38.9% | -24.8% | Zgodnie z | |
| ROA | -12.4%średnia z 5 lat ≈-20.6% | ≈-20.6% | -12.4% | Zgodnie z | |
| ROE | -57.6%średnia z 5 lat ≈-70.8% | ≈-70.8% | -50.5% | Słaby | |
| ROIC | -18.0%średnia z 5 lat ≈-68.2% | ≈-68.2% | · | · |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | AYTU | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Debt / Equity (Dług / Kapitał Własny) | 0.3średnia z 5 lat ≈0.4 | ≈0.4 | · | · | |
| Wskaźnik bieżący (MRQ) | 1.1średnia z 5 lat ≈1.1 | ≈1.1 | 1.4 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 0.9średnia z 5 lat ≈0.8 | ≈0.8 | 0.9 | Zgodnie z | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.3średnia z 5 lat ≈0.4 | ≈0.4 | · | · |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | AYTU | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | -13.3%średnia z 5 lat ≈1.5% | ≈1.5% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -18.8%średnia z 5 lat ≈6.6% | ≈6.6% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | -2.6% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | AYTU | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.5średnia z 5 lat ≈0.6 | ≈0.6 | 0.3 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 2.3średnia z 5 lat ≈2.6 | ≈2.6 | · | · | |
| Receivables Turnover (Rotacja należności) | 2.1średnia z 5 lat ≈3.2 | ≈3.2 | · | · | |
| Revenue / Employee (Przychody / pracownika) | ≈$767.6K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-1046.5%
Następny raport
Lis 11, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 września 2026 | Lis 11, 2026 | $-0.53 | $-0.34 | -55.1% |
| 30 czerwca 2026 | $-0.00 | $-0.33 | 99.7% | |
| 31 marca 2026 | Maj 13, 2026 | $-0.53 | $-0.52 | -1.9% |
| 31 grudnia 2025 | $-1.05 | $-0.61 | -71.6% | |
| 30 września 2025 | $0.21 | $-0.23 | 189.5% | |
| 30 czerwca 2025 | $-2.92 | $-0.04 | -7707.5% | |
| 31 marca 2025 | $0.21 | $-0.17 | 221.1% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $58M | $66M | $65M | $107M | $97M | $66M | $28M | $7M | $4M | $3M | $3M | $261.8K | |
| Cost of Revenue | $21M | $21M | $16M | $41M | $44M | $36M | $8M | $2M | $2M | $1M | $957.1K | $88.1K | |
| Gross Profit | $37M | $46M | $49M | $67M | $52M | $29M | $19M | · | · | · | · | · | |
| R&D Expense | $0 | $1M | $3M | $4M | $13M | $6M | $2M | $589.1K | $167.6K | $959.9K | $6M | $3M | |
| SG&A Expense | $19M | $17M | $20M | $29M | $31M | $26M | $20M | $19M | $18M | $17M | $9M | $4M | |
| Operating Expenses | $45M | $54M | $51M | $84M | $162M | $88M | $40M | $24M | $23M | $23M | $24M | $8M | |
| Operating Income | $-8M | $-8M | $-2M | $-17M | $-110M | $-59M | $-21M | $-17M | $-20M | $-20M | $-22M | $-8M | |
| Interest Expense | · | · | · | · | · | · | $3M | $535.5K | $749.4K | $3M | $5M | $115.0K | |
| Other Non-op | $713.0K | $-512.0K | $870.0K | $184.0K | $-757.0K | $-2M | $-3M | $-10M | $4M | $-2M | $-6M | $-115.0K | |
| Pretax Income | $-14M | $-14M | $-10M | $-17M | $-109M | $-58M | $-14M | · | · | · | $-28M | $-8M | |
| Income Tax | $21.0K | $437.0K | $2M | $0 | $-110.0K | $259.0K | $0 | $0 | $0 | · | $0 | $-23.9K | |
| Net Income | $-14M | $-14M | $-16M | $-17M | $-109M | $-58M | $-14M | $-27M | $-10M | $-23M | $-28M | $-8M | |
| EPS (Basic) | $-1.16 | $-2.16 | $-2.86 | $-5.11 | $-74.01 | $-3.48 | · | · | · | · | · | · | |
| EPS (Diluted) | · | · | · | $-5.11 | $-74.01 | $-3.48 | · | · | · | · | · | · | |
| Shares (Basic) | 12,318,817 | 6,279,744 | 5,537,957 | 3,339,906 | 1,469,875 | 16,746,679 | · | · | · | · | · | · | |
| Shares (Diluted) | · | · | · | 3,339,906 | 1,469,875 | 16,746,679 | · | · | · | · | · | · | |
| EBITDA | $-4M | $-2M | $3M | $-8M | $-101M | · | $-15M | $-14M | $-17M | · | $-21M | $-8M |
Bilans
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $31M | $20M | $23M | $19M | $50M | $48M | $11M | $7M | $802.3K | $8M | $7M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | $0 | $1M | $0 | |
| Receivables | $23M | $31M | $24M | $29M | $22M | $28M | $6M | $2M | $578.8K | $528.0K | $162.4K | $157.1K | |
| Inventory | $7M | $11M | $12M | $12M | $11M | $16M | $10M | $1M | $1M | $1M | $524.7K | $39.4K | |
| Prepaid Expense | $6M | $6M | $5M | $7M | $7M | $10M | $6M | $957.8K | $440.0K | $310.8K | $215.6K | $370.9K | |
| Other Current Assets | · | · | $62M | $71M | $633.0K | $1M | $6M | $0 | · | · | · | · | |
| Current Assets | $62M | $79M | $62M | $73M | $60M | $105M | $75M | $15M | $9M | $3M | $10M | $8M | |
| PP&E (Net) | $385.0K | $532.0K | $693.0K | $2M | · | · | $258.5K | $203.7K | $218.7K | $647.3K | $231.4K | $29.7K | |
| PP&E (Gross) | $1M | $1M | $3M | $5M | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $809.0K | $714.0K | $2M | $4M | · | · | $484.0K | $396.0K | $540.0K | $246.0K | $112.0K | $60.0K | |
| Goodwill | · | · | · | $0 | $0 | $66M | $28M | $0 | · | $238.4K | $221.0K | $74.0K | |
| Intangibles | $41M | $42M | $52M | $59M | $71M | $85M | $49M | $49M | $245.9K | $271.3K | $296.6K | $628.8K | |
| Other Non-current Assets | $601.0K | $1M | $2M | $3M | $766.0K | $465.0K | $33.0K | $19M | $11M | $9M | $11M | $0 | |
| Total Assets | $105M | $124M | $118M | $136M | $138M | $266M | $153M | $35M | $21M | $15M | $24M | $18M | |
| Accounts Payable | $11M | $11M | $10M | $13M | · | $19M | $12M | $2M | $2M | $2M | $2M | $1M | |
| Accrued Liabilities | $35M | $38M | $38M | $47M | $44M | $57M | $9M | $1M | $185.9K | $782.5K | $1M | · | |
| Short-term Debt | · | · | $2M | $2M | $4M | · | $982.1K | $0 | · | · | · | · | |
| Current Liabilities | $55M | $63M | $62M | $69M | $64M | $109M | $29M | $5M | $3M | $4M | $10M | $1M | |
| Capital Leases | $853.0K | $985.0K | $577.0K | $832.0K | $2M | $3M | $725.0K | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $41.4K | |
| Other Non-current Liabilities | $5M | $5M | $5M | $7M | $13M | $18M | $11.0K | $0 | · | · | · | · | |
| Total Liabilities | · | · | · | $97M | $93M | $128M | $58M | $28M | $8M | $11M | $14M | $3M | |
| Long-term Debt | $11M | $13M | $13M | $15M | $15M | · | · | $0 | $0 | · | · | · | |
| Total Debt | $11M | $13M | $15M | $2M | · | · | · | · | · | · | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $4.0K | $3.0K | $1.0K | $1.8K | $179 | $4 | $19 | $119 | |
| Paid-in Capital | $383M | $352M | $348M | $343M | · | $316M | $215M | $113M | $93M | $73M | · | · | |
| Retained Earnings | $-348M | $-334M | $-320M | $-304M | $-287M | $-178M | $-120M | $-106M | $-79M | $-69M | $-47M | $-18M | |
| Stockholders' Equity | $35M | $19M | $28M | $39M | $44M | $138M | $95M | $7M | $13M | $4M | $10M | $16M | |
| Liabilities + Equity | $105M | $124M | $118M | $136M | $138M | $266M | $153M | $35M | $21M | $15M | $24M | $18M | |
| Shares Outstanding | 10,728,208 | 8,976,913 | 5,972,638 | 5,517,174 | 1,928,941 | 27,490,412 | 12,583,736 | 17,538,071 | 1,794,762 | 41,244 | 187,098 | 1,188,307 |
Przepływy pieniężne
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $5M | $7M | $9M | $10M | $9M | $6M | $3M | $3M | $4M | $874.8K | $118.2K | |
| Stock-based Comp | $691.0K | $576.0K | $2M | $6M | $5M | $4M | $1M | $1M | $596.9K | $3M | $902.9K | $1M | |
| Deferred Tax | · | · | $0 | $-126.0K | $-117.0K | $243.0K | · | · | · | · | $0 | $-23.9K | |
| Amort. of Intangibles | $2M | $4M | $4M | $5M | $6M | $6M | $4M | $2M | $2M | $2M | $664.7K | $90.7K | |
| Restructuring | $0 | $2M | $2M | $0 | $0 | $5M | $667.0K | · | · | $1.5K | $0 | · | |
| Other Non-cash | $13M | $6M | $3M | $-3M | $66M | · | $-22M | $10M | $-9M | · | $16M | $-23.0K | |
| Operating Cash Flow | $3M | $-2M | $-1M | $-5M | $-29M | $-26M | $-28M | $-14M | $-16M | $-14M | $-11M | $-7M | |
| CapEx | $29.0K | $228.0K | $329.0K | · | $0 | $2M | $0 | $59.8K | $74.7K | $111.6K | $252.9K | $0 | |
| Investing Cash Flow | $-29.0K | $-3M | $-329.0K | $-117.0K | $-3M | $-3M | $-6M | $-1M | $-484.3K | $-4M | · | · | |
| Debt Issued | $0 | $2M | $13M | · | · | · | $640.0K | $0 | $0 | · | · | · | |
| Net Debt Issued | $-2M | $0 | $-16M | · | · | · | $640.0K | $5M | · | · | · | · | |
| Stock Issued | · | · | · | $16M | $12M | $45M | $66M | · | · | $739.9K | $0 | $0 | |
| Net Stock Activity | · | · | · | $16M | · | · | · | · | · | · | $8M | · | |
| Financing Cash Flow | $-8M | $15M | $-1M | $9M | $2M | $30M | $71M | $19M | $23M | $10M | · | · | |
| Net Change in Cash | $-5M | $11M | $-3M | $4M | $-31M | $2M | $37M | $4M | $6M | $-7M | $701.1K | $5M | |
| Taxes Paid | $211.0K | $1M | $2M | $0 | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $3M | $-2M | · | · | $-29M | · | $-28M | $-14M | $-16M | · | $-11M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $-16M | · |
Rentowność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.9% | 69.0% | 67.4% | 62.0% | 54.1% | · | · | · | · | · | · | · | |
| Operating Margin | -14.4% | -11.8% | -6.5% | -15.9% | -115.4% | · | -76.5% | -230.1% | -538.2% | · | -847.0% | -2915.5% | |
| Net Margin | -24.8% | -20.4% | -19.6% | -15.9% | -114.0% | · | -49.3% | -370.6% | -278.4% | · | -1099.7% | -2950.3% | |
| Pretax Margin | -24.7% | -20.7% | -17.4% | -15.9% | -114.1% | · | · | · | · | · | -1099.7% | -2959.4% | |
| EBITDA Margin | -7.6% | -3.7% | 3.7% | -7.7% | -104.8% | · | -53.9% | -192.9% | -467.4% | · | -812.9% | -2870.4% | |
| ROA | -12.4% | -11.2% | -12.4% | -12.4% | -54.6% | · | -14.5% | -97.3% | -56.5% | · | -132.5% | -84.7% | |
| ROE | -57.6% | -54.5% | -54.2% | -42.5% | -145.3% | · | -15.1% | -234.6% | -77.8% | · | -219.3% | -99.2% | |
| ROIC | -18.0% | -25.5% | -13.8% | -41.7% | -241.8% | · | · | · | · | · | -215.2% | -48.7% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.3 | · | 1.1 | 0.9 | · | 2.6 | 2.9 | 2.8 | · | 1.0 | 5.5 | |
| Quick Ratio | 0.9 | 1.0 | 0.7 | 0.8 | 0.6 | · | 1.9 | 2.4 | 2.2 | · | 0.9 | 5.1 | |
| Debt / Equity | 0.3 | 0.7 | 0.5 | 0.0 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.3 | 0.6 | 0.4 | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | -8.1 | -31.5 | -26.3 | · | -4.0 | · |
Efektywność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.6 | 0.8 | 0.5 | · | 0.3 | 0.3 | 0.2 | · | 0.1 | 0.0 | |
| Inventory Turnover | 2.3 | 1.7 | 2.1 | 3.6 | 3.3 | · | 1.3 | 1.6 | 1.5 | · | 3.4 | 4.5 | |
| Receivables Turnover | 2.1 | 2.4 | 3.1 | 4.2 | 3.9 | · | 8.0 | 6.3 | 6.6 | · | 16.0 | 3.3 |
Na akcję
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.29 | $2.11 | $4.64 | $7.13 | $1.19 | · | $0.76 | $0.40 | $7.48 | · | $2.70 | $1.10 | |
| Revenue / Share | · | · | · | $32.16 | $3.29 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | · | · | $-1.54 | $-0.98 | · | · | · | · | · | · | · | |
| Cash / Share | $2.45 | $3.45 | $3.35 | $4.17 | $0.50 | · | $0.38 | $0.63 | $3.91 | · | $2.15 | $0.52 | |
| EPS (TTM) | · | $-0.72 | $-3.97 | $-5.11 | $-74.01 | $-3.48 | · | · | · | · | · | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -13.3% | 1.8% | -39.3% | 11.1% | 47.3% | 137.5% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -18.8% | -11.8% | -0.23% | 57.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.6% | 19.2% | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $58M | $66M | $65M | $107M | $97M | $66M | $28M | $7M | $4M | $3M | $3M | $261.8K | |
| Net Income TTM | $-14M | $-14M | $-16M | $-17M | $-109M | $-58M | $-14M | $-27M | $-10M | $-23M | $-28M | $-8M | |
| Market Cap | $23M | $20M | $17M | $9M | $532M | · | $35.74B | $6.63B | $1.87B | · | $1.40T | $5.20T | |
| Enterprise Value | $8M | $1M | $13M | $-13M | · | · | · | · | · | · | · | · | |
| P/E | · | -3.0 | -0.7 | -0.3 | -0.2 | -28.8 | · | · | · | · | · | · | |
| P/S | 0.4 | 0.3 | 0.3 | 0.1 | 5.5 | · | 1293.3 | 905.6 | 510.0 | · | 546737.1 | 19871235.0 | |
| P/B | 0.7 | 1.0 | 0.6 | 0.2 | 11.6 | · | 376.1 | 935.3 | 139.0 | · | 138914.1 | 333105.9 | |
| P / Tangible Book | · | · | · | · | · | · | 1977.7 | · | · | · | · | · | |
| P / Cash Flow | 7.0 | -10.1 | -12.6 | -1.7 | -18.5 | · | -1259.5 | -479.3 | -117.1 | · | -131455.8 | -784106.7 | |
| P / FCF | · | -9.0 | · | · | -18.5 | · | -1259.5 | -477.2 | -116.6 | · | -128408.3 | · | |
| EV / EBITDA | · | -0.6 | 4.2 | 1.5 | · | · | · | · | · | · | · | · | |
| EV / FCF | · | -0.6 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.1 | 0.0 | 0.2 | -0.1 | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | -33.0% | -136.0% | -319.4% | -536.3% | -3.5% | · | · | · | · | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $12M | $15M | $14M | $15M | $18M | $16M | $17M | $15M | $14M | $19M | $18M | $31M | $23M | $26M | $28M | |
| Cost of Revenue | $6M | $5M | $6M | $5M | $5M | $6M | $5M | $5M | $4M | $4M | $4M | $5M | $12M | $10M | $9M | $10M | |
| Gross Profit | $10M | $8M | $10M | $9M | $10M | $13M | $11M | $12M | $11M | $10M | $15M | $13M | $19M | $13M | $17M | $18M | |
| R&D Expense | $0 | $0 | $0 | $0 | $216.0K | $162.0K | $522.0K | $426.0K | $1M | $611.0K | $521.0K | $595.0K | $465.0K | $856.0K | $2M | $1M | |
| SG&A Expense | $4M | $5M | $5M | $5M | $4M | $4M | $4M | $5M | $4M | $5M | $5M | $6M | $6M | $7M | $8M | $7M | |
| Operating Expenses | $11M | $12M | $12M | $11M | $18M | $10M | $12M | $13M | $13M | $12M | $11M | $14M | $18M | $21M | $24M | $20M | |
| Operating Income | $-777.0K | $-4M | $-2M | $-2M | $-8M | $2M | $-2M | $-930.0K | $-2M | $-2M | $3M | $-867.0K | $169.0K | $-9M | $-7M | $-2M | |
| Other Non-op | $173.0K | $149.0K | $190.0K | $201.0K | $-1M | $36.0K | $140.0K | $542.0K | $120.0K | $70.0K | $96.0K | $584.0K | $4M | $-1M | $-1M | $-1M | |
| Pretax Income | $-4.0K | $-6M | $-11M | $2M | $-19M | $4M | $382.0K | $1M | $-3M | $-2M | $1M | $-7M | $-2M | $-7M | $-7M | $-701.0K | |
| Income Tax | $11.0K | $10.0K | $0 | $0 | $437.0K | $-122.0K | $-283.0K | $405.0K | $841.0K | $521.0K | $780.0K | $0 | $0 | $0 | $0 | · | |
| Net Income | $-15.0K | $-6M | $-11M | $2M | $-20M | $4M | $788.0K | $1M | $-5M | $-3M | $-220.0K | $-8M | $-2M | $-7M | $-7M | $-701.0K | |
| EPS (Basic) | $0.21 | $-0.53 | $-1.05 | $0.21 | $-3.18 | $0.65 | $0.13 | $0.24 | $-0.82 | $-0.52 | $-0.04 | $-1.48 | $-0.75 | $-1.93 | $-2.15 | $-0.28 | |
| EPS (Diluted) | · | $-0.53 | $-1.05 | $-0.08 | · | $0.21 | $-0.26 | $-0.15 | · | $-0.52 | $-0.04 | $-1.48 | · | $-1.93 | $-2.15 | $-0.28 | |
| Shares (Basic) | · | 10,511,583 | 10,036,359 | 9,441,073 | · | 6,134,634 | 6,132,060 | 6,068,019 | · | 5,533,555 | 5,517,670 | 5,482,037 | · | 3,726,779 | 3,110,304 | 2,517,906 | |
| Shares (Diluted) | · | 10,511,583 | 10,036,359 | 19,476,635 | · | 8,204,453 | 8,485,112 | 9,099,601 | · | 5,533,555 | 5,517,670 | 5,482,037 | · | 3,726,779 | 3,110,304 | 2,517,906 | |
| EBITDA | · | $-4M | $-2M | $-701.0K | · | $2M | $-2M | $-930.0K | · | $-2M | $2M | $726.0K | · | $-9M | $-7M | $675.0K |
Bilans
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $27M | $30M | $33M | $31M | $18M | $20M | $20M | $20M | $20M | $20M | $20M | $23M | $19M | $20M | $24M | |
| Receivables | $23M | $24M | $31M | $33M | $31M | $36M | $25M | $23M | $24M | $30M | $29M | $30M | $29M | $34M | $26M | $28M | |
| Inventory | $7M | $7M | $9M | $10M | $11M | $11M | $11M | $12M | $12M | $13M | $13M | $13M | $12M | $14M | $13M | $13M | |
| Prepaid Expense | $6M | $9M | $7M | $5M | $6M | $7M | $6M | $6M | $5M | $7M | $8M | $7M | $7M | $10M | $12M | $9M | |
| Other Current Assets | · | · | · | · | · | · | $63M | $61M | · | $1M | $1M | $749.0K | $71M | $1M | $624.0K | $785.0K | |
| Current Assets | $62M | $67M | $76M | $81M | $79M | $73M | · | · | $62M | $71M | $71M | $71M | · | $78M | $71M | $74M | |
| PP&E (Net) | $385.0K | $407.0K | $484.0K | $500.0K | $532.0K | $546.0K | $516.0K | $692.0K | $693.0K | $967.0K | $1M | · | $2M | · | · | · | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $3M | $3M | $4M | $4M | · | $5M | · | · | · | |
| Accum. Depreciation | $809.0K | $802.0K | $768.0K | $735.0K | $714.0K | $690.0K | $651.0K | $2M | $2M | $3M | $3M | · | $4M | · | · | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Intangibles | $41M | $42M | $44M | $41M | $42M | $49M | $50M | $51M | $52M | $54M | $56M | $57M | $59M | $63M | $65M | $69M | |
| Other Non-current Assets | $601.0K | $556.0K | $738.0K | $939.0K | $1M | $1M | $2M | $2M | $2M | $889.0K | $907.0K | $772.0K | $3M | $892.0K | $821.0K | $829.0K | |
| Total Assets | $105M | $112M | $122M | $125M | $124M | $124M | $116M | $116M | $118M | $129M | $131M | $133M | $136M | $147M | $141M | $150M | |
| Accounts Payable | $11M | $13M | $14M | $12M | $11M | $12M | $12M | $14M | $10M | $10M | $10M | · | $13M | · | · | · | |
| Accrued Liabilities | $35M | $34M | $40M | $37M | $38M | $42M | $39M | $34M | $38M | $44M | $43M | $41M | $47M | $50M | $41M | $41M | |
| Short-term Debt | · | · | · | · | · | · | $4M | $4M | · | $2M | $1M | $1M | $2M | $10M | $7M | · | |
| Current Liabilities | $55M | $60M | $66M | $66M | $63M | $71M | $64M | $61M | $62M | $84M | $64M | $65M | $69M | $85M | $67M | $73M | |
| Capital Leases | $853.0K | $919.0K | $973.0K | $1M | $985.0K | $1M | $1M | $1M | $577.0K | $783.0K | · | $1M | $832.0K | $1M | $1M | $2M | |
| Other Non-current Liabilities | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $8M | $7M | $8M | $10M | $9M | |
| Total Liabilities | · | · | · | · | · | · | · | · | · | · | · | $101M | · | $106M | $96M | $102M | |
| Long-term Debt | $11M | $11M | $12M | $12M | $13M | $11M | $12M | $12M | · | $15M | $15M | $15M | $15M | $15M | $15M | $15M | |
| Total Debt | · | $11M | $12M | $12M | · | $11M | $16M | $17M | · | $17M | $16M | $1M | · | $10M | $7M | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | $6.0K | |
| Paid-in Capital | $383M | $383M | $356M | $355M | $352M | $349M | $348M | $348M | $348M | $346M | $345M | · | $343M | · | · | · | |
| Retained Earnings | $-348M | $-348M | $-342M | $-332M | $-334M | $-314M | $-318M | $-318M | $-320M | $-315M | $-312M | $-312M | $-304M | $-302M | $-294M | $-288M | |
| Stockholders' Equity | $35M | $35M | $14M | $23M | $19M | $35M | $31M | $30M | $28M | $31M | $33M | $32M | $39M | $41M | $46M | $48M | |
| Liabilities + Equity | $105M | $112M | $122M | $125M | $124M | $124M | $116M | $116M | $118M | $129M | $131M | $133M | $136M | $147M | $141M | $150M | |
| Shares Outstanding | 10,728,208 | 10,733,208 | 10,733,208 | 9,911,913 | 8,976,913 | 6,170,162 | 6,169,681 | 6,149,202 | 5,972,638 | 5,567,909 | 5,567,347 | 5,530,235 | 5,517,174 | 3,779,513 | 3,383,145 | 3,121,471 |
Przepływy pieniężne
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $885.0K | $803.0K | $1M | $1M | $1M | $1M | $2M | $758.0K | $1M | $-3M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $146.0K | $148.0K | $283.0K | $114.0K | $113.0K | $139.0K | $151.0K | $173.0K | $-188.0K | $811.0K | $820.0K | $930.0K | $900.0K | $902.0K | $3M | $1M | |
| Amort. of Intangibles | $761.0K | $761.0K | $526.0K | $444.0K | $921.0K | $920.0K | $921.0K | $921.0K | $921.0K | $920.0K | $918.0K | $924.0K | $1M | $1M | $1M | $1M | |
| Restructuring | $0 | $0 | $0 | $0 | $0 | $0 | $1M | $784.0K | $2M | $244.0K | $0 | $0 | · | · | · | · | |
| Other Non-cash | · | · | · | $-4M | · | · | · | · | · | · | · | $5M | · | · | · | · | |
| Operating Cash Flow | $4M | $-4M | $4M | $-618.0K | $3M | $-6M | $3M | $-1M | $-788.0K | $-300.0K | $-135.0K | $89.0K | $9M | $-3M | $-2M | $-9M | |
| CapEx | $12.0K | $0 | $17.0K | $0 | $17.0K | $69.0K | $6.0K | $136.0K | $329.0K | $0 | · | $0 | · | · | · | · | |
| Investing Cash Flow | $-12.0K | $0 | $-17.0K | $0 | $-3M | $-69.0K | $145.0K | $381.0K | $-34.0K | $-45.0K | $-174.0K | $174.0K | $-155.0K | $1.0K | $-5.0K | $42.0K | |
| Net Debt Issued | · | · | · | $-464.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-5M | $872.0K | $-6M | $2M | $13M | $4M | $-3M | $911.0K | $1M | $530.0K | $-126.0K | $126.0K | $-5M | $3M | $-2M | $14M | |
| Net Change in Cash | $-407.0K | $-3M | $-3M | $2M | $13M | $-2M | $290.0K | $102.0K | $246.0K | $231.0K | $-435.0K | $435.0K | $4M | $-322.0K | $-4M | $4M | |
| Taxes Paid | $10.0K | $0 | $61.0K | $140.0K | $0 | $0 | $973.0K | $446.0K | $1M | $130.0K | · | $-186.0K | $0 | $0 | · | · | |
| Free Cash Flow | · | · | · | $-618.0K | · | · | · | · | · | · | · | · | · | · | · | · |
Rentowność
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 61.2% | 63.5% | 66.1% | · | 69.4% | 66.5% | 72.3% | · | 65.0% | 70.7% | 66.9% | · | 56.1% | 65.8% | 65.2% | |
| Operating Margin | · | -32.8% | -13.0% | -10.8% | · | 13.1% | -10.4% | -5.6% | · | -13.7% | 10.3% | -6.8% | · | -37.6% | -25.9% | -6.0% | |
| Net Margin | · | -45.3% | -69.8% | 14.1% | · | 21.6% | 4.9% | 8.9% | · | -16.1% | -0.96% | -36.7% | · | -31.7% | -25.5% | · | |
| Pretax Margin | · | -45.2% | -69.8% | 14.1% | · | 20.7% | 2.4% | 9.0% | · | -14.7% | 2.6% | -36.7% | · | -31.7% | -25.5% | -2.5% | |
| EBITDA Margin | · | -32.8% | -13.0% | -5.1% | · | 13.1% | -10.4% | -5.6% | · | -13.7% | 10.3% | 3.3% | · | -37.6% | -25.9% | 2.4% | |
| ROA | · | -4.8% | -8.9% | 1.6% | · | 3.2% | 0.64% | 1.2% | · | -2.1% | -0.16% | -5.7% | · | -4.6% | -3.7% | · | |
| ROE | · | -16.0% | -47.1% | 7.4% | · | 12.2% | 2.5% | 4.8% | · | -8.1% | -0.56% | -20.2% | · | -14.1% | -8.8% | · | |
| ROIC | · | -8.8% | -7.6% | -4.2% | · | 5.4% | -6.3% | -1.5% | · | -5.7% | -1.8% | · | · | · | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.1 | 1.2 | 1.2 | · | 1.0 | · | · | · | 0.8 | 1.1 | 1.1 | · | 0.9 | 1.1 | 1.0 | |
| Quick Ratio | · | 0.9 | 0.9 | 1.0 | · | 0.8 | 0.7 | 0.7 | · | 0.6 | 0.8 | 0.8 | · | 0.6 | 0.7 | 0.7 | |
| Debt / Equity | · | 0.3 | 0.8 | 0.5 | · | 0.3 | 0.5 | 0.6 | · | 0.5 | 0.5 | 0.0 | · | 0.3 | 0.2 | · | |
| LT Debt / Equity | · | 0.3 | 0.7 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.0 | 0.5 | · | · | · | · | · |
Efektywność
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | |
| Inventory Turnover | · | 0.5 | 0.6 | 0.4 | · | 0.5 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.6 | · | 0.7 | 0.6 | 0.7 | |
| Receivables Turnover | · | 0.4 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.8 | 0.8 | · | 0.7 | 1.1 | 1.1 |
Na akcję
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $3.27 | $1.32 | $2.34 | · | $5.66 | $4.99 | $4.85 | · | $5.53 | $5.90 | $5.82 | · | $10.82 | $13.54 | $15.49 | |
| Revenue / Share | · | $1.18 | $1.51 | $0.71 | · | $2.25 | $1.91 | $1.82 | · | · | · | $4.03 | · | $6.10 | $8.45 | $10.98 | |
| Cash Flow / Share | · | · | · | $-0.03 | · | · | · | · | · | · | · | $-0.04 | · | · | · | $-3.63 | |
| Cash / Share | · | $2.49 | $2.80 | $3.29 | · | $2.95 | $3.31 | $3.27 | · | $3.55 | $3.51 | $3.61 | · | $5.07 | $5.76 | $7.63 | |
| EPS (TTM) | · | · | · | · | · | · | · | · | · | · | · | · | · | $-11.97 | $-45.94 | $-52.53 |
Wycena (TTM)
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $57M | $63M | $64M | · | $66M | $61M | $64M | · | $81M | $90M | $98M | · | $104M | $106M | $102M | |
| Net Income TTM | · | $-34M | $-24M | $-13M | · | $2M | $-5M | $-6M | · | $-14M | $-18M | $-24M | · | $-31M | $-77M | $-82M | |
| Market Cap | · | $29M | $28M | $19M | · | $7M | $10M | $14M | · | $17M | $16M | $15M | · | $8M | $13M | $12M | |
| Enterprise Value | · | $14M | $10M | $-2M | · | $623.2K | $6M | $11M | · | $14M | $12M | $-4M | · | $-309.9K | $784.0K | · | |
| P/E | · | · | · | · | · | · | · | · | · | · | · | · | · | -0.2 | -0.1 | -0.1 | |
| P/S | · | 0.5 | 0.4 | 0.3 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | 2.3 | |
| P/B | · | 0.8 | 2.0 | 0.8 | · | 0.2 | 0.3 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.2 | 0.3 | 0.2 | |
| P / Cash Flow | · | · | · | -30.2 | · | · | · | · | · | · | · | -70.8 | · | · | · | -1.3 | |
| EV / Revenue | · | 0.2 | 0.2 | -0.0 | · | 0.0 | 0.1 | 0.2 | · | 0.2 | 0.1 | -0.0 | · | -0.0 | 0.0 | · | |
| Earnings Yield | · | · | · | · | · | · | · | · | · | · | · | · | · | -534.4% | -1208.9% | -1382.4% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Przychody | $58M | $66M | $65M | $107M | $97M |
| Marża Brutto % | 63.9% | 69.0% | 67.4% | 62.0% | 54.1% |
| Marża Operacyjna % | -14.4% | -11.8% | -6.5% | -15.9% | -115.4% |
| Zysk netto | $-14M | $-14M | $-16M | $-17M | $-109M |
| Rozwodniony EPS | · | · | · | $-5.11 | $-74.01 |
| Wskaźnik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.3 | 0.7 | 0.5 | 0.0 | · |
| Wskaźnik bieżący | 1.1 | 1.3 | · | 1.1 | 0.9 |
| Wskaźnik Szybkości | 0.9 | 1.0 | 0.7 | 0.8 | 0.6 |
| Wskaźnik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $3M | $-2M | · | · | $-29M |
Właściciele instytucjonalni (13F) 43 emitenci · $9.1M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
43
Wartość posiadanych akcji
$9.1M
Nowe pozycje
3
Zamknięte pozycje
2
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 3 (-3 vs poprzedni kw.) | 2 (-1 vs poprzedni kw.) | 11 (+2 vs poprzedni kw.) | 5 (0 vs poprzedni kw.) | -67K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | $2 336 646 | 1 086 812 | 25,64% | Akcje |
| Stonepine Capital Management, LLC | $1 962 780 | 912 921 | 21,54% | Akcje |
| AWM Investment Company, Inc. | $1 332 084 | 619 574 | 14,62% | Akcje |
| VANGUARD GROUP INC | $724 316 | 278 583 | 7,95% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $561 464 | 261 146 | 6,16% | Akcje |
| CROWN ADVISORS MANAGEMENT, INC. | $430 000 | 200 000 | 4,72% | Akcje |
| DIADEMA PARTNERS LP | $319 374 | 148 546 | 3,50% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $226 451 | 105 326 | 2,48% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $225 369 | 104 823 | 2,47% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $201 371 | 93 647 | 2,21% | Akcje |
| TWO SIGMA ADVISERS, LP | $110 500 | 42 500 | 1,21% | Akcje |
| CITADEL ADVISORS LLC | $106 240 | 49 414 | 1,17% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $101 153 | 47 048 | 1,11% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $97 451 | 45 326 | 1,07% | Akcje |
| Persistent Asset Partners Ltd | $81 666 | 37 984 | 0,90% | Akcje |
| NORTHERN TRUST CORP | $60 039 | 27 925 | 0,66% | Akcje |
| BELLEVUE ASSET MANAGEMENT, LLC | $53 777 | 25 013 | 0,59% | Akcje |
| PERRITT CAPITAL MANAGEMENT INC | $52 000 | 20 000 | 0,57% | Akcje |
| BlackRock, Inc. | $49 005 | 22 793 | 0,54% | Akcje |
| XTX Topco Ltd | $46 044 | 21 416 | 0,51% | Akcje |
| Daytona Street Capital LLC | $22 350 | 10 000 | 0,25% | Akcje |
| UBS Group AG | $5 110 | 2 377 | 0,06% | Akcje |
| Tower Research Capital LLC (TRC) | $4 799 | 2 232 | 0,05% | Akcje |
| ROYAL BANK OF CANADA | $1 000 | 378 | 0,01% | Akcje |
| OSAIC HOLDINGS, INC. | $991 | 462 | 0,01% | Akcje |
| JPMORGAN CHASE & CO | $337 | 154 | 0,00% | Akcje |
| WELLS FARGO & COMPANY/MN | $273 | 127 | 0,00% | Akcje |
| MORGAN STANLEY | $269 | 125 | 0,00% | Akcje |
| CIBC Private Wealth Group LLC | $156 | 83 | 0,00% | Akcje |
| BARCLAYS PLC | $108 | 50 | 0,00% | Akcje |
| GROUP ONE TRADING LLC | $80 | 37 | 0,00% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $49 | 23 | 0,00% | Akcje |
| Rockefeller Capital Management L.P. | $22 | 10 | 0,00% | Akcje |
| SBI Securities Co., Ltd. | $22 | 10 | 0,00% | Akcje |
| Moser Wealth Advisors, LLC | $22 | 10 | 0,00% | Akcje |
| ACADIAN ASSET MANAGEMENT LLC | $22 | 10 237 | 0,00% | Akcje |
| Farther Finance Advisors, LLC | $9 | 4 | 0,00% | Akcje |
| VISION FINANCIAL MARKETS LLC | $5 | 2 | 0,00% | Akcje |
| Caitong International Asset Management Co., Ltd | $4 | 2 | 0,00% | Akcje |
| Arax Advisory Partners | $4 | 2 | 0,00% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $2 | 1 | 0,00% | Akcje |
| FNY Investment Advisers, LLC | $0 | 110 | 0,00% | Akcje |
| TSFG, LLC | $0 | 1 | 0,00% | Akcje |
Aktywiści i właściciele 5%+ 3 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC, Harkey Wilmot B., Mack Daniel ×4 zgłoszenia | 9 czerwca 2025 | 14,40% | Aneks | · | SEC |
| Armistice Capital, LLC, Steven Boyd ×12 zgłoszenia | 1 września 2021 | · | Pierwotne zgłoszenie | · | SEC |
| AMPIO PHARMACEUTICALS, INC. | 24 kwietnia 2015 | · | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 21 insiderów · 10 dyrektorzy generalni · 10 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Joshua R. Disbrow | Chief Executive Officer | 28 lipca 2026 A | 237 203 | 0 | 0 | $0 |
| Ryan J Selhorn | Chief Financial Officer | 28 lipca 2026 A | 74 743 | 0 | 0 | $0 |
| Mark K Oki | Chief Financial Officer | 11 sierpnia 2023 A | 190 000 | 0 | 0 | $0 |
| Richard I Eisenstadt | Chief Financial Officer | 31 marca 2021 A | 68 734 | 0 | 0 | $0 |
| David A Green | Chief Financial Officer | 8 czerwca 2020 A | 521 250 | 0 | 0 | $0 |
| Gregory A Gould | Chief Financial Officer | 16 marca 2017 A | 340 231 | 0 | 0 | $0 |
| Christopher Brooke | Chief Operating Officer | 11 sierpnia 2023 A | · | 0 | 0 | $0 |
| Greg Pyszczymuka | Chief Commercial Officer | 28 lipca 2026 A | 56 102 | 0 | 0 | $0 |
| Jarrett Disbrow | Chief Business Officer | 28 lipca 2026 A | 76 568 | 0 | 0 | $0 |
| Jonathan H Mcgrael | VP of Commercial Operations | 7 lipca 2016 A | 140 000 | 0 | 0 | $0 |
| Abhinav Jain | Dyrektor | 28 lipca 2026 A | 29 500 | 0 | 0 | $0 |
| John Donofrio Jr. | Dyrektor | 28 lipca 2026 A | 23 762 | 0 | 0 | $0 |
| Carl Dockery | Dyrektor | 28 lipca 2026 A | 31 152 | 0 | 0 | $0 |
| Vivian H Liu | Dyrektor | 28 lipca 2026 A | 29 825 | 0 | 0 | $0 |
| Gary Cantrell | Dyrektor | 21 grudnia 2022 D | 164 089 | 0 | 0 | $0 |
| Michael Macaluso | Dyrektor | 16 kwietnia 2021 A | 208 079 | 0 | 0 | $0 |
| Beth Hecht | Dyrektor | 8 kwietnia 2021 A | 9 052 | 0 | 0 | $0 |
| Gerald W. Mclaughlin | Dyrektor | 8 kwietnia 2021 A | 31 401 | 0 | 0 | $0 |
| Ketan Bhupatrai Mehta | Dyrektor | 8 czerwca 2020 A | 75 000 | 0 | 0 | $0 |
| Cerecor Inc. | Posiadacz 10% | 10 kwietnia 2020 C | 9 713 068 | 0 | 0 | $0 |
| Ampio Pharmaceuticals, Inc. | Posiadacz 10% | 1 grudnia 2015 J | 1 226 407 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 6 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| DFSU · Dimensional ETF Trust | 0,00% | 4 805 NS | 31 lipca 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 4 402 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 2 147 NS | 31 lipca 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 92 146 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 169 000 SH | 19 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,00% | 4 122 NS | 31 lipca 2026 | N-PORT |
AYTU Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 9 analityków
KUP
Średni cel
$7.00
+238,2%
2 22,2%
Mocne kupno
6 66,7%
Kup
1 11,1%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
3 analityków · 2026-09-28Średnia cel $9.50 +358,9%
← Poniżej wszystkich celów
Aktualna cena $2.07
Niski$7.00
Średnia$9.50
Wysoki$14.50
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-K złożone Wrz 22, 2026